and FR940525-0-00017 58 432 523 547 584 590 604 648 671 683 720 742 744 770 780 790 803 813 836 869 896 899 908 951 994 1055 1070 1165 1175 1193 1208 1298 1306 1327 1417 1581 1599 1612 1713 1938 2005 2008 2049 2065 2075 2079 2115 2159 2241 2261 2280 2298 2367 2416 2437 2451 2455 2605 2736
not FR940525-0-00017 17 433 628 704 1065 1071 1093 1291 1591 1652 1721 1752 1817 2110 2116 2141 2155 2160
in FR940525-0-00017 46 434 501 503 515 618 674 706 754 764 822 857 880 1120 1140 1221 1236 1274 1391 1521 1566 1662 1740 1771 1799 1873 1901 1915 1921 1956 1970 1983 2196 2216 2251 2307 2377 2402 2540 2568 2582 2588 2623 2633 2654 2670 2696
the FR940525-0-00017 102 435 464 497 504 516 555 599 608 663 666 675 689 707 712 716 727 737 760 765 773 778 858 890 904 925 945 1082 1123 1145 1168 1186 1229 1239 1245 1395 1404 1435 1451 1465 1468 1495 1514 1562 1579 1588 1604 1623 1641 1676 1679 1682 1703 1709 1733 1759 1795 1827 1870 1874 1877 1889 1898 1902 1905 1916 1945 2122 2166 2170 2175 2199 2221 2248 2253 2267 2291 2304 2309 2324 2373 2378 2381 2413 2418 2476 2485 2494 2537 2541 2544 2556 2565 2569 2572 2583 2612 2630 2655 2677 2686 2691 2712
public FR940525-0-00017 2 436 840
interest FR940525-0-00017 1 437
. FR940525-0-00017 107 438 448 472 490 509 530 551 560 657 748 777 826 876 886 942 959 975 996 1050 1085 1098 1110 1115 1130 1139 1177 1203 1217 1243 1309 1343 1353 1359 1376 1393 1406 1428 1449 1463 1472 1490 1493 1501 1507 1550 1557 1577 1586 1602 1617 1627 1640 1670 1678 1697 1702 1725 1732 1757 1779 1792 1820 1825 1947 1952 1961 1966 1991 2025 2030 2051 2068 2084 2101 2134 2138 2151 2169 2186 2191 2206 2215 2263 2282 2320 2342 2362 2371 2380 2392 2398 2431 2474 2487 2492 2614 2619 2644 2650 2661 2666 2680 2685 2716 2720 2738 2742
this FR940525-0-00017 21 439 507 539 693 768 783 830 1128 1150 1224 1536 1619 1777 1814 1959 1973 2204 2226 2626 2673 2705
final FR940525-0-00017 2 440 540
rule FR940525-0-00017 2 441 541
, FR940525-0-00017 101 442 444 447 450 454 458 459 482 526 577 578 589 597 598 601 603 615 635 668 670 695 715 739 757 785 795 800 802 809 812 832 853 872 888 893 895 910 948 950 989 991 993 1008 1010 1015 1019 1026 1028 1030 1035 1037 1042 1046 1152 1172 1174 1182 1188 1226 1250 1263 1287 1297 1311 1315 1318 1322 1326 1414 1416 1441 1456 1594 1610 1622 1766 1794 2044 2046 2048 2058 2060 2228 2258 2260 2272 2274 2277 2279 2287 2293 2314 2353 2410 2439 2628 2675 2719 2724 2727 2731
therefore FR940525-0-00017 2 443 887
is FR940525-0-00017 26 445 645 703 915 963 998 1052 1064 1092 1470 1590 1647 1651 1687 1691 1716 1720 1747 1751 2001 2055 2105 2109 2130 2136 2154
effective FR940525-0-00017 1 446
however FR940525-0-00017 2 449 1793
interested FR940525-0-00017 1 451
persons FR940525-0-00017 1 452
may FR940525-0-00017 6 453 486 512 542 627 854
on FR940525-0-00017 7 455 574 594 606 1081 1167 2243
or FR940525-0-00017 10 456 575 595 633 696 710 815 849 2072 2094
before FR940525-0-00017 3 457 576 596
submit FR940525-0-00017 2 460 487
written FR940525-0-00017 2 461 580
comments FR940525-0-00017 5 462 477 491 511 811
to FR940525-0-00017 29 463 479 493 545 565 611 805 903 934 965 968 1142 1233 1271 1400 1474 1478 1538 1885 2012 2015 2091 2132 2174 2218 2460 2481 2552 2709
dockets FR940525-0-00017 4 465 517 774 859
management FR940525-0-00017 4 466 518 775 860
branch FR940525-0-00017 4 467 519 776 861
( FR940525-0-00017 87 468 571 591 729 734 846 862 954 976 983 999 1014 1059 1086 1099 1111 1131 1159 1178 1204 1213 1269 1333 1338 1350 1354 1373 1407 1422 1502 1523 1526 1529 1532 1551 1628 1635 1644 1671 1684 1698 1705 1726 1737 1773 1801 1804 1807 1810 1821 1859 1879 1948 1962 1985 1988 2031 2038 2180 2183 2187 2207 2235 2245 2264 2283 2301 2321 2327 2343 2363 2393 2404 2407 2424 2471 2488 2526 2546 2615 2635 2638 2645 2662 2681 2698 2701
address FR940525-0-00017 2 469 863
above FR940525-0-00017 2 470 864
) FR940525-0-00017 87 471 573 593 731 736 848 865 958 978 985 1004 1020 1061 1088 1101 1113 1133 1161 1180 1206 1215 1276 1335 1340 1352 1356 1375 1409 1424 1504 1525 1528 1531 1534 1553 1630 1637 1646 1673 1686 1700 1707 1728 1742 1775 1803 1806 1809 1812 1823 1862 1891 1950 1964 1987 1990 2033 2040 2182 2185 2189 2209 2237 2247 2266 2285 2303 2323 2329 2345 2365 2395 2406 2409 2426 2473 2490 2529 2558 2617 2637 2640 2647 2664 2683 2700 2703
two FR940525-0-00017 1 473
copies FR940525-0-00017 2 474 756
of FR940525-0-00017 93 475 506 582 651 665 686 718 767 788 798 817 878 906 944 987 1076 1125 1127 1147 1149 1163 1210 1223 1238 1260 1303 1383 1411 1434 1447 1461 1486 1513 1535 1542 1546 1561 1574 1659 1664 1667 1675 1681 1730 1735 1743 1776 1813 1829 1833 1839 1869 1876 1897 1904 1930 1934 1944 1958 1972 2042 2063 2097 2121 2124 2126 2149 2201 2203 2223 2225 2239 2338 2369 2428 2467 2496 2500 2506 2536 2543 2564 2571 2597 2601 2611 2625 2641 2672 2690 2704 2711 2729
any FR940525-0-00017 3 476 531 561
are FR940525-0-00017 7 478 492 820 1329 1783 1790 2010
be FR940525-0-00017 11 480 494 513 535 558 752 855 1118 1818 2194 2388
submitted FR940525-0-00017 1 481
except FR940525-0-00017 5 483 833 1227 2333 2411
that FR940525-0-00017 10 484 643 653 680 1057 1886 2128 2553 2642 2710
individuals FR940525-0-00017 1 485
one FR940525-0-00017 2 488 2071
copy FR940525-0-00017 1 489
identified FR940525-0-00017 2 495 758
with FR940525-0-00017 12 496 711 759 772 1122 1144 1267 1476 1516 2198 2220 2457
docket FR940525-0-00017 2 498 761
number FR940525-0-00017 3 499 762 2123
found FR940525-0-00017 1 500
brackets FR940525-0-00017 1 502
heading FR940525-0-00017 2 505 766
document FR940525-0-00017 2 508 769
received FR940525-0-00017 1 510
seen FR940525-0-00017 2 514 856
between FR940525-0-00017 4 520 866 1304 1708
9 FR940525-0-00017 2 521 867
am FR940525-0-00017 3 522 868 2748
4 FR940525-0-00017 4 524 870 2158 2663
pm FR940525-0-00017 2 525 871
monday FR940525-0-00017 2 527 873
through FR940525-0-00017 4 528 874 1378 1607
friday FR940525-0-00017 2 529 875
person FR940525-0-00017 4 532 562 609 728
who FR940525-0-00017 3 533 563 732
will FR940525-0-00017 2 534 722
adversely FR940525-0-00017 1 536
affected FR940525-0-00017 1 537
by FR940525-0-00017 5 538 692 1185 2178 2290
file FR940525-0-00017 2 543 570
objections FR940525-0-00017 1 544
it FR940525-0-00017 16 546 659 1051 1102 1116 1650 1690 1719 1750 2069 2108 2129 2135 2139 2164 2192
request FR940525-0-00017 9 548 585 623 676 699 733 791 1155 2231
a FR940525-0-00017 57 549 567 579 587 613 622 625 646 655 678 698 701 746 786 793 796 807 818 967 977 1047 1104 1258 1264 1288 1299 1339 1379 1423 1440 1480 1533 1540 1567 1571 1608 1636 1845 1853 1865 1881 1893 1976 2032 2056 2080 2181 2246 2302 2336 2433 2462 2512 2520 2532 2548 2560
hearing FR940525-0-00017 14 550 556 568 588 614 626 656 679 702 738 747 794 808 819
reasonable FR940525-0-00017 1 552
grounds FR940525-0-00017 1 553
for FR940525-0-00017 27 554 586 624 677 700 792 834 928 980 1108 1135 1170 1190 1453 1583 1711 1888 2035 2211 2255 2269 2295 2330 2346 2385 2555 2733
must FR940525-0-00017 5 557 569 637 751 2387
shown FR940525-0-00017 1 559
decides FR940525-0-00017 1 564
seek FR940525-0-00017 1 566
1 FR940525-0-00017 14 572 984 1214 1527 1805 1844 2039 2184 2328 2394 2408 2511 2639 2702
notice FR940525-0-00017 2 581 787
participation FR940525-0-00017 2 583 789
2 FR940525-0-00017 14 592 1045 1112 1293 1615 1724 1755 1852 1949 1989 2188 2344 2519 2616
data FR940525-0-00017 4 600 667 799 835
information FR940525-0-00017 4 602 669 801 837
analyses FR940525-0-00017 4 605 673 714 804
which FR940525-0-00017 1 607
relies FR940525-0-00017 1 610
justify FR940525-0-00017 2 612 806
as FR940525-0-00017 23 616 917 936 970 1219 1282 1330 1618 1769 1835 1954 1968 1981 2003 2017 2375 2400 2421 2502 2621 2652 2668 2694
specified FR940525-0-00017 1 617
21 FR940525-0-00017 7 619 823 843 881 911 929 955
cfr FR940525-0-00017 5 620 824 882 912 930
314.300. FR940525-0-00017 1 621
rest FR940525-0-00017 1 629
upon FR940525-0-00017 1 630
mere FR940525-0-00017 1 631
allegations FR940525-0-00017 1 632
denials FR940525-0-00017 1 634
but FR940525-0-00017 1 636
set FR940525-0-00017 1 638
forth FR940525-0-00017 1 639
specific FR940525-0-00017 1 640
facts FR940525-0-00017 1 641
showing FR940525-0-00017 1 642
there FR940525-0-00017 1 644
genuine FR940525-0-00017 2 647 682
substantial FR940525-0-00017 2 649 684
issue FR940525-0-00017 2 650 685
fact FR940525-0-00017 2 652 687
requires FR940525-0-00017 1 654
if FR940525-0-00017 11 658 697 1183 1587 1649 1689 1718 1749 1758 2107 2288
conclusively FR940525-0-00017 1 660
appears FR940525-0-00017 1 661
from FR940525-0-00017 5 662 839 1499 1995 2445
face FR940525-0-00017 1 664
factual FR940525-0-00017 1 672
no FR940525-0-00017 1 681
precludes FR940525-0-00017 1 688
action FR940525-0-00017 1 690
taken FR940525-0-00017 1 691
order FR940525-0-00017 3 694 784 831
made FR940525-0-00017 1 705
required FR940525-0-00017 4 708 713 1184 2289
format FR940525-0-00017 1 709
commissioner FR940525-0-00017 2 717 905
food FR940525-0-00017 4 719 892 907 947
drugs FR940525-0-00017 3 721 909 923
enter FR940525-0-00017 1 723
summary FR940525-0-00017 1 724
judgment FR940525-0-00017 1 725
against FR940525-0-00017 1 726
s FR940525-0-00017 12 730 735 1003 1738 1849 1854 1894 1911 2516 2521 2561 2578
making FR940525-0-00017 3 740 2252 2308
findings FR940525-0-00017 1 741
conclusions FR940525-0-00017 1 743
denying FR940525-0-00017 1 745
all FR940525-0-00017 3 749 827 2331
submissions FR940525-0-00017 2 750 828
filed FR940525-0-00017 3 753 771 2744
three FR940525-0-00017 1 755
appearing FR940525-0-00017 1 763
procedures FR940525-0-00017 1 779
requirements FR940525-0-00017 11 781 979 1124 1146 1325 1633 1762 1789 2034 2200 2222
governing FR940525-0-00017 1 782
submission FR940525-0-00017 1 797
other FR940525-0-00017 1 810
grant FR940525-0-00017 1 814
denial FR940525-0-00017 1 816
contained FR940525-0-00017 1 821
314.300 FR940525-0-00017 1 825
under FR940525-0-00017 4 829 842 889 900
prohibited FR940525-0-00017 1 838
disclosure FR940525-0-00017 1 841
usc FR940525-0-00017 3 844 851 956
331 FR940525-0-00017 1 845
j FR940525-0-00017 1 847
18 FR940525-0-00017 1 850
1905 FR940525-0-00017 1 852
list FR940525-0-00017 1 877
subjects FR940525-0-00017 1 879
part FR940525-0-00017 4 883 913 920 931
442 FR940525-0-00017 3 884 914 932
antibiotics FR940525-0-00017 1 885
federal FR940525-0-00017 2 891 946
drug FR940525-0-00017 5 894 949 1191 2296 2734
cosmetic FR940525-0-00017 2 897 952
act FR940525-0-00017 2 898 953
authority FR940525-0-00017 3 901 926 939
delegated FR940525-0-00017 1 902
amended FR940525-0-00017 1 916
follows FR940525-0-00017 8 918 937 971 1331 1836 2018 2422 2503
: FR940525-0-00017 27 919 938 940 972 1058 1158 1195 1332 1346 1348 1365 1369 1371 1837 1864 2019 2234 2244 2300 2311 2326 2335 2349 2423 2504 2531 2718
442_cepha FR940525-0-00017 1 921
antibiotic FR940525-0-00017 1 922
1. FR940525-0-00017 1 924
citation FR940525-0-00017 1 927
continues FR940525-0-00017 1 933
read FR940525-0-00017 3 935 969 2016
sec FR940525-0-00017 1 941
507 FR940525-0-00017 1 943
357 FR940525-0-00017 1 957
2. FR940525-0-00017 1 960
new FR940525-0-00017 2 961 2006
§442.52 FR940525-0-00017 4 962 973 2179 2403
added FR940525-0-00017 2 964 2011
subpart FR940525-0-00017 2 966 2013
cefotetan FR940525-0-00017 41 974 997 1077 1109 1436 1469 1487 1547 1712 1830 1840 1871 1899 1906 1913 1917 2021 2027 2052 2064 2088 2098 2103 2127 2150 2171 2249 2256 2270 2305 2396 2419 2468 2497 2507 2538 2566 2573 2580 2584 2713
certification FR940525-0-00017 4 981 1136 2036 2212
_ FR940525-0-00017 6 982 1212 1337 1421 1634 2037
standards FR940525-0-00017 3 986 2041 2176
identity FR940525-0-00017 9 988 1106 1176 1965 2043 2167 2262 2281 2684
strength FR940525-0-00017 2 990 2045
quality FR940525-0-00017 2 992 2047
purity FR940525-0-00017 2 995 2050
6 FR940525-0-00017 1 1000
r FR940525-0-00017 3 1001 1706 1739
,7 FR940525-0-00017 1 1002
-4- FR940525-0-00017 1 1005
[ FR940525-0-00017 7 1006 1007 1012 1013 1031 1993 2739
- FR940525-0-00017 5 1009 1025 1027 1029 1036
-3- FR940525-0-00017 1 1011
-1 FR940525-0-00017 2 1016 1041
h FR940525-0-00017 1 1017
-tetrazol- FR940525-0-00017 1 1018
thio FR940525-0-00017 1 1021
] FR940525-0-00017 7 1022 1024 1033 1038 1040 1997 2749
methyl FR940525-0-00017 1 1023
4.2 FR940525-0-00017 1 1032
oct- FR940525-0-00017 1 1034
-carbamoyl FR940525-0-00017 1 1039
,- FR940525-0-00017 1 1043
d FR940525-0-00017 2 1044 1727
-malonamic FR940525-0-00017 1 1048
acid FR940525-0-00017 3 1049 1364 1368
so FR940525-0-00017 1 1053
purified FR940525-0-00017 1 1054
dried FR940525-0-00017 1 1056
i FR940525-0-00017 6 1060 1160 1334 1530 2236 2425
its FR940525-0-00017 7 1062 1089 1401 1714 2102 2152 2482
potency FR940525-0-00017 6 1063 1171 1216 2257 2271 2397
less FR940525-0-00017 4 1066 1722 2111 2156
than FR940525-0-00017 13 1067 1073 1095 1388 1654 1693 1723 1754 2112 2118 2143 2157 2162
950 FR940525-0-00017 1 1068
micrograms FR940525-0-00017 8 1069 1075 1485 1545 1828 1922 2466 2589
more FR940525-0-00017 9 1072 1094 1596 1653 1753 2073 2117 2142 2161
1030 FR940525-0-00017 1 1074
activity FR940525-0-00017 3 1078 1914 2581
per FR940525-0-00017 15 1079 1295 1488 1548 1831 1841 1923 1932 2099 2147 2469 2498 2508 2590 2599
milligram FR940525-0-00017 5 1080 1832 1842 2148 2509
anhydrous FR940525-0-00017 1 1083
basis FR940525-0-00017 1 1084
ii FR940525-0-00017 6 1087 1179 1408 1808 2284 2489
moisture FR940525-0-00017 6 1090 1173 1942 1951 2259 2609
content FR940525-0-00017 5 1091 1943 2104 2420 2610
2.5 FR940525-0-00017 1 1096
percent FR940525-0-00017 9 1097 1658 1666 1741 1756 1941 2114 2120 2608
iii FR940525-0-00017 2 1100 1629
gives FR940525-0-00017 1 1103
positive FR940525-0-00017 1 1105
test FR940525-0-00017 7 1107 1231 1320 1419 1555 2168 2660
labeling FR940525-0-00017 3 1114 2190 2379
shall FR940525-0-00017 4 1117 1156 2193 2232
labeled FR940525-0-00017 2 1119 2195
accordance FR940525-0-00017 2 1121 2197
§432.5 FR940525-0-00017 2 1126 2202
chapter FR940525-0-00017 10 1129 1151 1225 1778 1960 1974 2205 2227 2627 2674
3 FR940525-0-00017 5 1132 1270 1963 2208 2646
requests FR940525-0-00017 2 1134 2210
; FR940525-0-00017 11 1137 1892 1909 1925 1937 2213 2559 2576 2592 2604 2746
samples FR940525-0-00017 4 1138 1181 2214 2286
addition FR940525-0-00017 2 1141 2217
complying FR940525-0-00017 2 1143 2219
§431.1 FR940525-0-00017 2 1148 2224
each FR940525-0-00017 7 1153 1198 2085 2229 2315 2359 2446
such FR940525-0-00017 3 1154 1281 2230
contain FR940525-0-00017 3 1157 2133 2233
results FR940525-0-00017 2 1162 2238
tests FR940525-0-00017 5 1164 1207 2240 2332 2366
assays FR940525-0-00017 2 1166 2242
batch FR940525-0-00017 5 1169 2254 2268 2310 2325
director FR940525-0-00017 3 1187 2292 2726
center FR940525-0-00017 3 1189 2294 2732
evaluation FR940525-0-00017 3 1192 2297 2735
research FR940525-0-00017 3 1194 2299 2737
10 FR940525-0-00017 7 1196 1272 1305 1559 1584 1657 2312
packages FR940525-0-00017 2 1197 2313
containing FR940525-0-00017 6 1199 1444 1482 1570 2316 2464
approximately FR940525-0-00017 5 1200 1431 1483 1543 2317
500 FR940525-0-00017 2 1201 2318
milligrams FR940525-0-00017 10 1202 1433 1573 1929 2093 2096 2125 2319 2495 2596
b FR940525-0-00017 14 1205 1355 1503 1524 1672 1774 1802 1811 1986 2265 2322 2364 2405 2699
methods FR940525-0-00017 2 1209 2368
assay FR940525-0-00017 3 1211 1246 2370
proceed FR940525-0-00017 8 1218 1768 1953 1967 2399 2620 2651 2667
directed FR940525-0-00017 9 1220 1955 1969 2376 2401 2622 2653 2669 2695
§436.216 FR940525-0-00017 2 1222 1772
use FR940525-0-00017 2 1228 1613
resolution FR940525-0-00017 7 1230 1235 1319 1418 1554 1701 1704
solution FR940525-0-00017 27 1232 1242 1314 1317 1321 1342 1427 1481 1498 1506 1519 1556 1565 1589 1606 1620 1920 1936 2062 2383 2415 2430 2463 2478 2587 2603 2679
determine FR940525-0-00017 1 1234
lieu FR940525-0-00017 2 1237 1663
working FR940525-0-00017 12 1240 1312 1412 1425 1437 1496 1563 1907 1918 2574 2585 2714
standard FR940525-0-00017 14 1241 1313 1413 1426 1438 1497 1564 1890 1908 1919 2557 2575 2586 2715
perform FR940525-0-00017 1 1244
at FR940525-0-00017 7 1247 1257 1656 1880 2355 2389 2547
ambient FR940525-0-00017 1 1248
temperature FR940525-0-00017 3 1249 2391 2454
using FR940525-0-00017 5 1251 1975 2432 2629 2676
an FR940525-0-00017 3 1252 1509 2441
ultraviolet FR940525-0-00017 1 1253
detection FR940525-0-00017 1 1254
system FR940525-0-00017 5 1255 1323 1631 1760 1787
operating FR940525-0-00017 1 1256
wavelength FR940525-0-00017 1 1259
254 FR940525-0-00017 1 1261
nanometers FR940525-0-00017 1 1262
column FR940525-0-00017 3 1265 1677 1683
packed FR940525-0-00017 1 1266
microparticulate FR940525-0-00017 1 1268
micrometers FR940525-0-00017 1 1273
diameter FR940525-0-00017 2 1275 1392
reversed FR940525-0-00017 1 1277
phase FR940525-0-00017 4 1278 1358 1397 2459
packing FR940525-0-00017 1 1279
material FR940525-0-00017 1 1280
octadecyl FR940525-0-00017 1 1283
hydrocarbon FR940525-0-00017 1 1284
bonded FR940525-0-00017 1 1285
silicas FR940525-0-00017 1 1286
flow FR940525-0-00017 1 1289
rate FR940525-0-00017 1 1290
exceeding FR940525-0-00017 1 1292
milliliters FR940525-0-00017 4 1294 1446 1460 1560
minute FR940525-0-00017 1 1296
known FR940525-0-00017 1 1300
injection FR940525-0-00017 3 1301 2029 2054
volume FR940525-0-00017 2 1302 1475
20 FR940525-0-00017 3 1307 2092 2350
microliters FR940525-0-00017 1 1308
reagents FR940525-0-00017 2 1310 1336
sample FR940525-0-00017 21 1316 1415 1505 1515 1796 1834 1878 1931 1935 1946 2374 2382 2414 2429 2477 2501 2545 2598 2602 2613 2692
suitability FR940525-0-00017 4 1324 1632 1761 1788
calculations FR940525-0-00017 1 1328
diluting FR940525-0-00017 2 1341 1518
mix FR940525-0-00017 3 1344 1360 1491
water FR940525-0-00017 2 1345 1477
methanol FR940525-0-00017 3 1347 1370 1448
acetonitrile FR940525-0-00017 3 1349 1372 1462
90:5:5 FR940525-0-00017 1 1351
mobile FR940525-0-00017 3 1357 1396 2458
0.1 FR940525-0-00017 1 1361
m FR940525-0-00017 5 1362 1861 1939 2528 2606
phosphoric FR940525-0-00017 1 1363
glacial FR940525-0-00017 1 1366
acetic FR940525-0-00017 1 1367
1700:100:105:105 FR940525-0-00017 1 1374
filter FR940525-0-00017 4 1377 1381 1603 1611
suitable FR940525-0-00017 3 1380 2074 2434
capable FR940525-0-00017 1 1382
removing FR940525-0-00017 1 1384
particulate FR940525-0-00017 1 1385
matter FR940525-0-00017 1 1386
greater FR940525-0-00017 2 1387 1692
0.5 FR940525-0-00017 1 1389
micron FR940525-0-00017 1 1390
degas FR940525-0-00017 1 1394
just FR940525-0-00017 2 1398 2479
prior FR940525-0-00017 2 1399 2480
introduction FR940525-0-00017 2 1402 2483
into FR940525-0-00017 3 1403 1439 2484
chromatograph FR940525-0-00017 2 1405 2486
preparation FR940525-0-00017 3 1410 1797 2427
solutions FR940525-0-00017 1 1420
accurately FR940525-0-00017 3 1429 1510 2442
weigh FR940525-0-00017 1 1430
50 FR940525-0-00017 1 1432
volumetric FR940525-0-00017 1 1442
flask FR940525-0-00017 5 1443 1452 1466 1569 1580
12.5 FR940525-0-00017 2 1445 1459
swirl FR940525-0-00017 2 1450 1464
several FR940525-0-00017 1 1454
minutes FR940525-0-00017 2 1455 1585
then FR940525-0-00017 2 1457 1767
add FR940525-0-00017 2 1458 1595
until FR940525-0-00017 1 1467
dissolved FR940525-0-00017 1 1471
dilute FR940525-0-00017 2 1473 2456
obtain FR940525-0-00017 3 1479 1539 2461
200 FR940525-0-00017 3 1484 1544 2465
milliliter FR940525-0-00017 10 1489 1549 1924 1933 2086 2100 2470 2499 2591 2600
well FR940525-0-00017 1 1492
protect FR940525-0-00017 1 1494
light FR940525-0-00017 1 1500
dissolve FR940525-0-00017 1 1508
weighed FR940525-0-00017 1 1511
portion FR940525-0-00017 2 1512 2444
sufficient FR940525-0-00017 1 1517
described FR940525-0-00017 5 1520 1770 1798 1982 2632
paragraph FR940525-0-00017 4 1522 1800 2634 2697
section FR940525-0-00017 5 1537 1815 1999 2643 2706
concentration FR940525-0-00017 2 1541 1625
c FR940525-0-00017 7 1552 1699 1856 1926 2014 2523 2593
place FR940525-0-00017 1 1558
stoppered FR940525-0-00017 1 1568
few FR940525-0-00017 1 1572
magnesium FR940525-0-00017 2 1575 1597
carbonate FR940525-0-00017 2 1576 1598
close FR940525-0-00017 1 1578
sonicate FR940525-0-00017 1 1582
slightly FR940525-0-00017 1 1592
turbid FR940525-0-00017 2 1593 1605
repeat FR940525-0-00017 1 1600
sonication FR940525-0-00017 1 1601
0. FR940525-0-00017 1 1609
within FR940525-0-00017 1 1614
hours FR940525-0-00017 1 1616
stands FR940525-0-00017 1 1621
tautomer FR940525-0-00017 2 1624 1715
increases FR940525-0-00017 1 1626
tailing FR940525-0-00017 2 1638 1642
factor FR940525-0-00017 2 1639 1643
t FR940525-0-00017 1 1645
satisfactory FR940525-0-00017 5 1648 1688 1717 1748 2106
1.3 FR940525-0-00017 1 1655
peak FR940525-0-00017 7 1660 1668 1710 1872 1900 2539 2567
height FR940525-0-00017 2 1661 1669
5 FR940525-0-00017 2 1665 2682
efficiency FR940525-0-00017 2 1674 1680
n FR940525-0-00017 1 1685
1500 FR940525-0-00017 1 1694
theoretical FR940525-0-00017 1 1695
plates FR940525-0-00017 1 1696
coefficient FR940525-0-00017 2 1729 1734
variation FR940525-0-00017 2 1731 1736
five FR940525-0-00017 1 1744
replicate FR940525-0-00017 1 1745
injections FR940525-0-00017 1 1746
have FR940525-0-00017 1 1763
been FR940525-0-00017 1 1764
met FR940525-0-00017 2 1765 1791
alternate FR940525-0-00017 1 1780
chromatographic FR940525-0-00017 1 1781
conditions FR940525-0-00017 1 1782
acceptable FR940525-0-00017 1 1784
provided FR940525-0-00017 1 1785
comparable FR940525-0-00017 1 1786
should FR940525-0-00017 1 1816
changed FR940525-0-00017 1 1819
iv FR940525-0-00017 1 1822
calculation FR940525-0-00017 2 1824 2491
calculate FR940525-0-00017 3 1826 2417 2493
1micrograms FR940525-0-00017 2 1838 2505
1= FR940525-0-00017 2 1843 2510
u FR940525-0-00017 8 1846 1857 1866 1927 2513 2524 2533 2594
x FR940525-0-00017 8 1847 1850 1855 1858 2514 2517 2522 2525
p FR940525-0-00017 4 1848 1910 2515 2577
100 FR940525-0-00017 2 1851 2518
100- FR940525-0-00017 2 1860 2527
where FR940525-0-00017 2 1863 2530
= FR940525-0-00017 10 1867 1895 1912 1928 1940 2534 2562 2579 2595 2607
area FR940525-0-00017 4 1868 1896 2535 2563
chromatogram FR940525-0-00017 5 1875 1903 2542 2570 2689
retention FR940525-0-00017 2 1882 2549
time FR940525-0-00017 2 1883 2550
equal FR940525-0-00017 2 1884 2551
observed FR940525-0-00017 2 1887 2554
§436.201 FR940525-0-00017 1 1957
§436.211 FR940525-0-00017 2 1971 1984
mineral FR940525-0-00017 1 1977
oil FR940525-0-00017 1 1978
mull FR940525-0-00017 1 1979
prepared FR940525-0-00017 1 1980
§442.253a FR940525-0-00017 2 1992 2004
redesignated FR940525-0-00017 2 1994 2002
§442.253 FR940525-0-00017 2 1996 2020
3. FR940525-0-00017 1 1998
442.253 FR940525-0-00017 1 2000
§§442.253 FR940525-0-00017 1 2007
442.253b FR940525-0-00017 1 2009
injectable FR940525-0-00017 1 2022
dosage FR940525-0-00017 1 2023
forms FR940525-0-00017 1 2024
§442.253b FR940525-0-00017 1 2026
sodium FR940525-0-00017 3 2028 2053 2066
frozen FR940525-0-00017 1 2057
aqueous FR940525-0-00017 1 2059
isoosmotic FR940525-0-00017 1 2061
bicarbonate FR940525-0-00017 1 2067
contains FR940525-0-00017 3 2070 2087 2140
harmless FR940525-0-00017 1 2076
buffer FR940525-0-00017 1 2077
substances FR940525-0-00017 1 2078
tonicity FR940525-0-00017 1 2081
adjusting FR940525-0-00017 1 2082
agent FR940525-0-00017 1 2083
disodium FR940525-0-00017 1 2089
equivalent FR940525-0-00017 1 2090
40 FR940525-0-00017 1 2095
90 FR940525-0-00017 1 2113
120 FR940525-0-00017 1 2119
represented FR940525-0-00017 1 2131
sterile FR940525-0-00017 1 2137
0.17 FR940525-0-00017 1 2144
endotoxin FR940525-0-00017 1 2145
units FR940525-0-00017 1 2146
ph FR940525-0-00017 3 2153 2278 2665
6.5. FR940525-0-00017 1 2163
passes FR940525-0-00017 1 2165
used FR940525-0-00017 4 2172 2250 2306 2384
conforms FR940525-0-00017 1 2173
prescribed FR940525-0-00017 1 2177
sterility FR940525-0-00017 4 2273 2334 2347 2618
bacterial FR940525-0-00017 3 2275 2648 2658
endotoxins FR940525-0-00017 3 2276 2649 2659
minimum FR940525-0-00017 1 2337
12 FR940525-0-00017 1 2339
immediate FR940525-0-00017 2 2340 2351
containers FR940525-0-00017 2 2341 2352
testing FR940525-0-00017 2 2348 2386
collected FR940525-0-00017 1 2354
regular FR940525-0-00017 1 2356
intervals FR940525-0-00017 1 2357
throughout FR940525-0-00017 1 2358
filling FR940525-0-00017 1 2360
operation FR940525-0-00017 1 2361
thaw FR940525-0-00017 1 2372
room FR940525-0-00017 2 2390 2453
prepare FR940525-0-00017 2 2412 2475
hypodermic FR940525-0-00017 1 2435
needle FR940525-0-00017 1 2436
syringe FR940525-0-00017 1 2438
remove FR940525-0-00017 1 2440
measured FR940525-0-00017 1 2443
container FR940525-0-00017 1 2447
immediately FR940525-0-00017 1 2448
after FR940525-0-00017 1 2449
thawing FR940525-0-00017 1 2450
reaching FR940525-0-00017 1 2452
estimated FR940525-0-00017 1 2472
§436.20 FR940525-0-00017 1 2624
method FR940525-0-00017 1 2631
e FR940525-0-00017 1 2636
us FR940525-0-00017 1 2656
pharmacopeia FR940525-0-00017 1 2657
§436.202 FR940525-0-00017 1 2671
undiluted FR940525-0-00017 1 2678
highperformance FR940525-0-00017 1 2687
liquid FR940525-0-00017 1 2688
determined FR940525-0-00017 1 2693
compares FR940525-0-00017 1 2707
qualitatively FR940525-0-00017 1 2708
dated FR940525-0-00017 1 2717
gayle FR940525-0-00017 1 2721
r. FR940525-0-00017 1 2722
dolecek FR940525-0-00017 1 2723
acting FR940525-0-00017 1 2725
office FR940525-0-00017 1 2728
compliance FR940525-0-00017 1 2730
fr FR940525-0-00017 1 2740
doc FR940525-0-00017 1 2741
9412667 FR940525-0-00017 1 2743
52494 FR940525-0-00017 1 2745
8:45 FR940525-0-00017 1 2747
billing FR940525-0-00017 1 2750
code FR940525-0-00017 1 2751
416001f FR940525-0-00017 1 2752
21 FR940525-0-00018 10 0 207 267 284 336 408 460 499 520 546
cfr FR940525-0-00018 8 1 208 268 285 409 461 500 521
part FR940525-0-00018 7 2 264 269 462 501 508 522
520 FR940525-0-00018 4 3 463 502 523
oral FR940525-0-00018 2 4 71
dosage FR940525-0-00018 2 5 510
form FR940525-0-00018 2 6 511
new FR940525-0-00018 5 7 53 224 512 649
animal FR940525-0-00018 7 8 44 54 145 464 513 650
drugs FR940525-0-00018 4 9 465 489 514
; FR940525-0-00018 2 10 666
proban FR940525-0-00018 3 11 79 172
® FR940525-0-00018 3 12 80 173
( FR940525-0-00018 35 13 38 57 76 81 115 174 266 274 277 280 283 287 290 293 313 316 319 322 335 339 342 345 348 411 414 417 545 561 568 580 586 597 609 620
cythioate FR940525-0-00018 4 14 82 175 577
) FR940525-0-00018 35 15 40 59 78 83 117 176 271 276 279 282 289 292 295 296 315 318 321 324 341 344 347 350 351 413 416 419 549 563 570 582 588 599 611 622
tablets FR940525-0-00018 3 16 578 612
agency FR940525-0-00018 2 17 404
: FR940525-0-00018 11 18 27 32 99 106 137 507 529 531 575 638
food FR940525-0-00018 7 19 34 119 328 472 487 538
and FR940525-0-00018 17 20 35 120 201 272 332 384 391 476 479 488 490 542 558 564 607 613
drug FR940525-0-00018 10 21 36 45 55 121 241 330 474 540 651
administration FR940525-0-00018 3 22 37 122
, FR940525-0-00018 42 23 63 75 94 100 110 118 123 127 129 132 139 141 144 148 152 155 158 163 171 183 199 200 254 297 329 331 352 390 443 468 473 475 498 539 541 608 629 639 644 646 653
hhs FR940525-0-00018 1 24
. FR940525-0-00018 25 25 30 96 101 134 191 214 229 252 309 361 402 441 455 466 533 550 579 590 593 616 631 640 658 662
action FR940525-0-00018 2 26 422
final FR940525-0-00018 1 28
rule FR940525-0-00018 1 29
summary FR940525-0-00018 2 31 302
the FR940525-0-00018 27 33 43 65 70 88 93 167 181 192 202 212 247 258 306 326 362 367 379 387 397 403 438 470 484 493 516 536
fda FR940525-0-00018 2 39 374
is FR940525-0-00018 7 41 195 303 423 453 503 554
amending FR940525-0-00018 1 42
regulations FR940525-0-00018 2 46 203
to FR940525-0-00018 11 47 87 180 210 243 375 396 483 492 525 571
reflect FR940525-0-00018 2 48 211
approval FR940525-0-00018 6 49 213 215 354 389 398
of FR940525-0-00018 24 50 73 92 169 187 198 216 223 235 260 263 300 325 386 399 424 457 486 535 600 605 623 628 648
a FR940525-0-00018 9 51 74 170 236 298 425 434 562 581
supplemental FR940525-0-00018 4 52 66 160 193
application FR940525-0-00018 1 56
nada FR940525-0-00018 4 58 67 161 194
filed FR940525-0-00018 3 60 159 664
by FR940525-0-00018 4 61 373 556 565
miles FR940525-0-00018 2 62 138
inc. FR940525-0-00018 2 64 140
provides FR940525-0-00018 3 68 165 232
for FR940525-0-00018 13 69 102 112 166 185 233 305 358 495 519 603 626 655
use FR940525-0-00018 7 72 91 168 234 250 604 627
mg FR940525-0-00018 2 77 610
tablet FR940525-0-00018 6 84 95 177 184 238 630
in FR940525-0-00018 8 85 178 206 255 378 459 595 618
addition FR940525-0-00018 2 86 179
currently FR940525-0-00018 2 89 248
approved FR940525-0-00018 4 90 182 196 249
effective FR940525-0-00018 1 97
date FR940525-0-00018 1 98
further FR940525-0-00018 1 103
information FR940525-0-00018 4 104 136 261 301
contact FR940525-0-00018 1 105
marcia FR940525-0-00018 1 107
k. FR940525-0-00018 1 108
larkins FR940525-0-00018 1 109
center FR940525-0-00018 3 111 494 654
veterinary FR940525-0-00018 3 113 496 656
medicine FR940525-0-00018 3 114 497 657
hfv112 FR940525-0-00018 1 116
7500 FR940525-0-00018 1 124
standish FR940525-0-00018 1 125
pl. FR940525-0-00018 1 126
rockville FR940525-0-00018 1 128
md FR940525-0-00018 1 130
20855 FR940525-0-00018 1 131
3015940614 FR940525-0-00018 1 133
supplementary FR940525-0-00018 1 135
agriculture FR940525-0-00018 1 142
division FR940525-0-00018 1 143
health FR940525-0-00018 1 146
products FR940525-0-00018 1 147
po FR940525-0-00018 1 149
box FR940525-0-00018 1 150
390 FR940525-0-00018 1 151
shawnee FR940525-0-00018 1 153
mission FR940525-0-00018 1 154
ks FR940525-0-00018 1 156
66201 FR940525-0-00018 1 157
132337 FR940525-0-00018 1 162
which FR940525-0-00018 1 164
control FR940525-0-00018 1 186
fleas FR940525-0-00018 1 188
on FR940525-0-00018 2 189 437
dogs FR940525-0-00018 1 190
as FR940525-0-00018 5 197 371 505 527 573
are FR940525-0-00018 1 204
amended FR940525-0-00018 3 205 504 555
520.531 FR940525-0-00018 2 209 553
this FR940525-0-00018 7 217 230 353 400 421 601 624
supplement FR940525-0-00018 4 218 231 368 401
does FR940525-0-00018 3 219 355 428
not FR940525-0-00018 4 220 356 394 429
require FR940525-0-00018 1 221
submission FR940525-0-00018 1 222
safety FR940525-0-00018 2 225 383
or FR940525-0-00018 2 226 431
effectiveness FR940525-0-00018 2 227 385
data FR940525-0-00018 2 228 381
larger FR940525-0-00018 1 237
with FR940525-0-00018 3 239 257 366
increased FR940525-0-00018 1 240
concentration FR940525-0-00018 1 242
be FR940525-0-00018 1 244
given FR940525-0-00018 1 245
at FR940525-0-00018 1 246
level FR940525-0-00018 1 251
however FR940525-0-00018 1 253
accordance FR940525-0-00018 1 256
freedom FR940525-0-00018 2 259 299
provisions FR940525-0-00018 1 262
20 FR940525-0-00018 2 265 270
§514.11 FR940525-0-00018 1 273
e FR940525-0-00018 2 275 288
2 FR940525-0-00018 4 278 291 317 343
ii FR940525-0-00018 2 281 294
514.11 FR940525-0-00018 1 286
provided FR940525-0-00018 1 304
revised FR940525-0-00018 1 307
labeling FR940525-0-00018 1 308
under FR940525-0-00018 4 310 407 469 480
section FR940525-0-00018 2 311 552
512 FR940525-0-00018 2 312 534
c FR940525-0-00018 4 314 340 598 621
f FR940525-0-00018 2 320 346
iii FR940525-0-00018 3 323 349 418
federal FR940525-0-00018 3 327 471 537
cosmetic FR940525-0-00018 3 333 477 543
act FR940525-0-00018 3 334 478 544
usc FR940525-0-00018 2 337 547
360b FR940525-0-00018 2 338 548
qualify FR940525-0-00018 1 357
marketing FR940525-0-00018 1 359
exclusivity FR940525-0-00018 1 360
additional FR940525-0-00018 1 363
studies FR940525-0-00018 1 364
submitted FR940525-0-00018 1 365
were FR940525-0-00018 2 369 393
conducted FR940525-0-00018 1 370
requested FR940525-0-00018 1 372
correct FR940525-0-00018 1 376
deficiencies FR940525-0-00018 1 377
original FR940525-0-00018 1 380
supporting FR940525-0-00018 1 382
1968 FR940525-0-00018 1 388
they FR940525-0-00018 1 392
essential FR940525-0-00018 1 395
has FR940525-0-00018 1 405
determined FR940525-0-00018 1 406
25.24 FR940525-0-00018 1 410
d FR940525-0-00018 1 412
1 FR940525-0-00018 1 415
that FR940525-0-00018 2 420 427
type FR940525-0-00018 1 426
individually FR940525-0-00018 1 430
cumulatively FR940525-0-00018 1 432
have FR940525-0-00018 1 433
significant FR940525-0-00018 1 435
effect FR940525-0-00018 1 436
human FR940525-0-00018 1 439
environment FR940525-0-00018 1 440
therefore FR940525-0-00018 2 442 467
neither FR940525-0-00018 1 444
an FR940525-0-00018 2 445 449
environmental FR940525-0-00018 2 446 450
assessment FR940525-0-00018 1 447
nor FR940525-0-00018 1 448
impact FR940525-0-00018 1 451
statement FR940525-0-00018 1 452
required FR940525-0-00018 1 454
list FR940525-0-00018 1 456
subjects FR940525-0-00018 1 458
authority FR940525-0-00018 3 481 517 530
delegated FR940525-0-00018 1 482
commissioner FR940525-0-00018 1 485
redelegated FR940525-0-00018 1 491
follows FR940525-0-00018 3 506 528 574
520_oral FR940525-0-00018 1 509
1. FR940525-0-00018 1 515
citation FR940525-0-00018 1 518
continues FR940525-0-00018 1 524
read FR940525-0-00018 2 526 572
sec FR940525-0-00018 1 532
2. FR940525-0-00018 1 551
removing FR940525-0-00018 1 557
reserving FR940525-0-00018 1 559
paragraph FR940525-0-00018 2 560 567
revising FR940525-0-00018 1 566
b FR940525-0-00018 2 569 587
§520.531 FR940525-0-00018 1 576
[ FR940525-0-00018 2 583 659
reserved FR940525-0-00018 1 584
] FR940525-0-00018 2 585 669
sponsors FR940525-0-00018 1 589
see FR940525-0-00018 2 591 614
no FR940525-0-00018 2 592 615
000859 FR940525-0-00018 1 594
§510.600 FR940525-0-00018 2 596 619
chapter FR940525-0-00018 2 602 625
30- FR940525-0-00018 1 606
010042 FR940525-0-00018 1 617
* FR940525-0-00018 5 632 633 634 635 636
dated FR940525-0-00018 1 637
robert FR940525-0-00018 1 641
c. FR940525-0-00018 1 642
livingston FR940525-0-00018 1 643
director FR940525-0-00018 1 645
office FR940525-0-00018 1 647
evaluation FR940525-0-00018 1 652
fr FR940525-0-00018 1 660
doc FR940525-0-00018 1 661
9412664 FR940525-0-00018 1 663
52494 FR940525-0-00018 1 665
8:45 FR940525-0-00018 1 667
am FR940525-0-00018 1 668
billing FR940525-0-00018 1 670
code FR940525-0-00018 1 671
416001f FR940525-0-00018 1 672
21 FR940525-0-00019 5 0 263 338 355 452
cfr FR940525-0-00019 4 1 264 339 356
parts FR940525-0-00019 1 2
520 FR940525-0-00019 1 3
and FR940525-0-00019 21 4 11 20 35 121 175 179 184 196 213 257 266 292 305 343 373 376 398 418 448 491
556 FR940525-0-00019 1 5
animal FR940525-0-00019 3 6 44 54
drugs FR940525-0-00019 1 7
, FR940525-0-00019 33 8 10 23 101 111 119 124 128 130 133 142 147 149 152 189 235 238 242 245 255 256 287 368 396 401 405 409 411 414 421 445 447 467
feeds FR940525-0-00019 1 9
related FR940525-0-00019 1 12
products FR940525-0-00019 1 13
; FR940525-0-00019 1 14
fenbendazole FR940525-0-00019 4 15 73 169 195
suspension FR940525-0-00019 3 16 74 165
agency FR940525-0-00019 2 17 521
: FR940525-0-00019 6 18 27 32 100 107 138
food FR940525-0-00019 6 19 34 120 397 444 495
drug FR940525-0-00019 9 21 36 45 55 91 122 299 399 446
administration FR940525-0-00019 6 22 37 71 123 162 400
hhs FR940525-0-00019 1 24
. FR940525-0-00019 17 25 30 80 97 102 135 144 187 205 230 248 272 285 325 403 425 519
action FR940525-0-00019 1 26
final FR940525-0-00019 1 28
rule FR940525-0-00019 1 29
summary FR940525-0-00019 3 31 284 370
the FR940525-0-00019 19 33 43 65 81 225 249 258 270 273 280 288 298 329 389 442 510 517 520 525
( FR940525-0-00019 25 38 57 116 219 232 337 345 348 351 354 358 361 364 393 429 432 435 438 451 455 458 461 464 483 498
fda FR940525-0-00019 1 39
) FR940525-0-00019 24 40 59 118 221 234 342 347 350 353 360 363 366 367 395 431 434 437 440 457 460 463 466 490 505
is FR940525-0-00019 5 41 203 207 251 277
amending FR940525-0-00019 1 42
regulations FR940525-0-00019 4 46 82 259 289
to FR940525-0-00019 9 47 75 86 170 268 310 314 379 507
reflect FR940525-0-00019 2 48 269
approval FR940525-0-00019 7 49 206 271 276 381 469 508
of FR940525-0-00019 14 50 72 163 177 194 254 282 297 331 334 371 382 441 509
a FR940525-0-00019 6 51 88 154 164 190 369
supplemental FR940525-0-00019 3 52 66 155
new FR940525-0-00019 3 53 478 493
application FR940525-0-00019 2 56 384
nada FR940525-0-00019 3 58 67 156
filed FR940525-0-00019 2 60 153
by FR940525-0-00019 2 61 516
hoechstroussel FR940525-0-00019 2 62 139
agrivet FR940525-0-00019 2 63 140
co. FR940525-0-00019 2 64 141
provides FR940525-0-00019 2 68 159
for FR940525-0-00019 12 69 90 103 113 160 173 192 275 290 295 321 473
oral FR940525-0-00019 2 70 161
goats FR940525-0-00019 2 76 172
as FR940525-0-00019 2 77 253
an FR940525-0-00019 1 78
anthelmintic FR940525-0-00019 1 79
are FR940525-0-00019 4 83 260 307 319
also FR940525-0-00019 2 84 188
amended FR940525-0-00019 2 85 261
establish FR940525-0-00019 1 87
tolerance FR940525-0-00019 2 89 191
residues FR940525-0-00019 3 92 193 296
in FR940525-0-00019 9 93 199 209 215 262 279 303 326 388
edible FR940525-0-00019 2 94 200
goat FR940525-0-00019 2 95 201
tissues FR940525-0-00019 2 96 202
effective FR940525-0-00019 1 98
date FR940525-0-00019 1 99
further FR940525-0-00019 1 104
information FR940525-0-00019 6 105 137 214 283 332 377
contact FR940525-0-00019 1 106
george FR940525-0-00019 1 108
k. FR940525-0-00019 1 109
haibel FR940525-0-00019 1 110
center FR940525-0-00019 1 112
veterinary FR940525-0-00019 1 114
medicine FR940525-0-00019 1 115
hfv133 FR940525-0-00019 1 117
7500 FR940525-0-00019 1 125
standish FR940525-0-00019 1 126
pl. FR940525-0-00019 1 127
rockville FR940525-0-00019 2 129 410
md FR940525-0-00019 2 131 412
20855 FR940525-0-00019 1 132
3015941644 FR940525-0-00019 1 134
supplementary FR940525-0-00019 1 136
rt FR940525-0-00019 1 143
202206 FR940525-0-00019 1 145
north FR940525-0-00019 1 146
somerville FR940525-0-00019 1 148
nj FR940525-0-00019 1 150
08876 FR940525-0-00019 1 151
128620 FR940525-0-00019 1 157
that FR940525-0-00019 1 158
containing FR940525-0-00019 1 166
10 FR940525-0-00019 1 167
percent FR940525-0-00019 1 168
nonlactating FR940525-0-00019 1 171
removal FR940525-0-00019 1 174
control FR940525-0-00019 1 176
stomach FR940525-0-00019 1 178
intestinal FR940525-0-00019 1 180
worms FR940525-0-00019 1 181
haemonchus FR940525-0-00019 1 182
contortus FR940525-0-00019 1 183
ostertagia FR940525-0-00019 1 185
circumcincta FR940525-0-00019 1 186
its FR940525-0-00019 2 197 301
metabolites FR940525-0-00019 2 198 302
established FR940525-0-00019 2 204 223
based FR940525-0-00019 1 208
part FR940525-0-00019 3 210 335 340
on FR940525-0-00019 1 211
data FR940525-0-00019 2 212 375
public FR940525-0-00019 1 216
master FR940525-0-00019 1 217
file FR940525-0-00019 1 218
pmf FR940525-0-00019 1 220
5118 FR940525-0-00019 1 222
under FR940525-0-00019 2 224 426
interregional FR940525-0-00019 1 226
research FR940525-0-00019 1 227
project FR940525-0-00019 1 228
no FR940525-0-00019 3 229 477 492
4 FR940525-0-00019 2 231 419
ir4 FR940525-0-00019 1 233
northcentral FR940525-0-00019 1 236
region FR940525-0-00019 1 237
michigan FR940525-0-00019 1 239
state FR940525-0-00019 1 240
university FR940525-0-00019 1 241
east FR940525-0-00019 1 243
lansing FR940525-0-00019 1 244
mi FR940525-0-00019 1 246
48824 FR940525-0-00019 1 247
supplement FR940525-0-00019 2 250 511
approved FR940525-0-00019 1 252
520.905a FR940525-0-00019 1 265
556.275 FR940525-0-00019 1 267
basis FR940525-0-00019 1 274
discussed FR940525-0-00019 1 278
freedom FR940525-0-00019 2 281 330
additionally FR940525-0-00019 1 286
tolerances FR940525-0-00019 1 291
safe FR940525-0-00019 2 293 315
concentrations FR940525-0-00019 2 294 316
or FR940525-0-00019 5 300 480 487 502 514
cattle FR940525-0-00019 1 304
swine FR940525-0-00019 1 306
editorially FR940525-0-00019 1 308
revised FR940525-0-00019 1 309
remove FR940525-0-00019 1 311
any FR940525-0-00019 1 312
reference FR940525-0-00019 1 313
because FR940525-0-00019 2 317 476
they FR940525-0-00019 1 318
irrelevant FR940525-0-00019 1 320
residue FR940525-0-00019 3 322 488 503
monitoring FR940525-0-00019 1 323
purposes FR940525-0-00019 1 324
accordance FR940525-0-00019 1 327
with FR940525-0-00019 1 328
provisions FR940525-0-00019 1 333
20 FR940525-0-00019 2 336 341
§514.11 FR940525-0-00019 1 344
e FR940525-0-00019 2 346 359
2 FR940525-0-00019 4 349 362 433 459
ii FR940525-0-00019 2 352 365
514.11 FR940525-0-00019 1 357
safety FR940525-0-00019 2 372 496
effectiveness FR940525-0-00019 1 374
submitted FR940525-0-00019 1 378
support FR940525-0-00019 1 380
this FR940525-0-00019 2 383 468
may FR940525-0-00019 1 385
be FR940525-0-00019 1 386
seen FR940525-0-00019 1 387
dockets FR940525-0-00019 1 390
management FR940525-0-00019 1 391
branch FR940525-0-00019 1 392
hfa305 FR940525-0-00019 1 394
rm FR940525-0-00019 1 402
123 FR940525-0-00019 1 404
12420 FR940525-0-00019 1 406
parklawn FR940525-0-00019 1 407
dr. FR940525-0-00019 1 408
20857 FR940525-0-00019 1 413
between FR940525-0-00019 1 415
9 FR940525-0-00019 1 416
am FR940525-0-00019 1 417
pm FR940525-0-00019 1 420
monday FR940525-0-00019 1 422
through FR940525-0-00019 1 423
friday FR940525-0-00019 1 424
section FR940525-0-00019 1 427
512 FR940525-0-00019 1 428
c FR940525-0-00019 2 430 456
f FR940525-0-00019 2 436 462
iii FR940525-0-00019 2 439 465
federal FR940525-0-00019 1 443
cosmetic FR940525-0-00019 1 449
act FR940525-0-00019 1 450
usc FR940525-0-00019 1 453
360b FR940525-0-00019 1 454
does FR940525-0-00019 1 470
not FR940525-0-00019 1 471
qualify FR940525-0-00019 1 472
marketing FR940525-0-00019 1 474
exclusivity FR940525-0-00019 1 475
clinical FR940525-0-00019 1 479
field FR940525-0-00019 1 481
investigations FR940525-0-00019 1 482
other FR940525-0-00019 2 484 499
than FR940525-0-00019 2 485 500
bioequivalence FR940525-0-00019 2 486 501
studies FR940525-0-00019 3 489 497 504
human FR940525-0-00019 1 494
essential FR940525-0-00019 1 506
were FR940525-0-00019 1 512
conducted FR940525-0-00019 1 513
sponsored FR940525-0-00019 1 515
applicant FR940525-0-00019 1 518
has FR940525-0-00019 1 522
carefully FR940525-0-00019 1 523
considered FR940525-0-00019 1 524
potential FR940525-0-00019 1 526
environmental FR940525-0-00019 1 527
